Catalyst Wire Dossier Catalyst Wire Dossier

FOLFIRINOX regimen (folinic acid, fluorouracil, irinotecan, oxaliplatin)

FOLFIRINOX
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FOLFIRINOX regimen (folinic acid, fluorouracil, irinotecan, oxaliplatin), covering 2020-05-07 to 2025-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Efficacy and the Safety of FOLFIRINOX3 Bevacizumab Treatment in Patients With Colorectal Cancer (FOLFIRINOX 3) [Phase 1, Phase 2]

See pricing